anti-Trop2 antibody-drug conjugate (Peak Bio/Dren Bio/3T Biosciences/Neuron23/Aarvik Therapeutics)

N/A

Report date: 2025/01/26 18:26:43

Base Information

Drug Nameanti-Trop2 antibody-drug conjugate (Peak Bio/Dren Bio/3T Biosciences/Neuron23/Aarvik Therapeutics)
Drug Alias NameM2.8 PH1 ADC
ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate
Mechanisms of ActionTumor-associated calcium signal transducer 2 modulators
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeak Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeak Bio IncAarvik Therapeutics Inc3T Biosciences Inc +[5] 
Inactive CompaniesN/A
Active IndicationsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A